Article
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jun 2010
Harrison Christine J, Hills Robert K, Moorman Anthony V, Grimwade David J, Hann Ian, Webb David K H, Wheatley Keith, de Graaf Siebold S N, van den Berg Eva, Burnett Alan K, Gibson Brenda E S
Abstract excerpt
PURPOSE: Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance of individual chromosomal abnormalities in this age group remains unclear. PATIENTS AND MET...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
